<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39301475</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Long COVID and hypermobility spectrum disorders have shared pathophysiology.</ArticleTitle><Pagination><StartPage>1455498</StartPage><MedlinePgn>1455498</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1455498</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2024.1455498</ELocationID><Abstract><AbstractText>Hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS) are the most common joint hypermobility conditions encountered by physicians, with hypermobile and classical EDS accounting for &gt;90% of all cases. Hypermobility has been detected in up to 30-57% of patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), fibromyalgia, postural orthostatic tachycardia syndrome (POTS), and long COVID (LC) compared to the general population. Extrapulmonary symptoms, including musculoskeletal pain, dysautonomia disorders, cognitive disorders, and fatigue, are seen in both LC and HSD. Additionally, ME/CFS has overlapping symptoms with those seen in HSD. Mast cell activation and degranulation occurring in both LC and ME/CFS may result in hyperinflammation and damage to connective tissue in these patients, thereby inducing hypermobility. Persistent inflammation may result in the development or worsening of HSD. Hence, screening for hypermobility and other related conditions including fibromyalgia, POTS, ME/CFS, chronic pain conditions, joint pain, and myalgia is essential for individuals experiencing LC. Pharmacological treatments should be symptom-focused and geared to a patient's presentation. Paced exercise, massage, yoga, and meditation may also provide benefits.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Ganesh and Munipalli.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ganesh</LastName><ForeName>Ravindra</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Rochester, MN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Munipalli</LastName><ForeName>Bala</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Mayo Clinic, Jacksonville, FL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hypermobile Ehlers&#x2013;Danlos syndrome</Keyword><Keyword MajorTopicYN="N">hypermobility spectrum disorders</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">postural orthostatic tachycardia syndrome</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>21</Day><Hour>13</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>21</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>20</Day><Hour>4</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39301475</ArticleId><ArticleId IdType="pmc">PMC11410636</ArticleId><ArticleId IdType="doi">10.3389/fneur.2024.1455498</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yew KS, Kamps-Schmitt KA, Borge R. Hypermobile Ehlers&#x2013;Danlos syndrome and hypermobility spectrum disorders. Am Fam Physician. (2021) 103:481&#x2013;92. PMID:</Citation><ArticleIdList><ArticleId IdType="pubmed">33856167</ArticleId></ArticleIdList></Reference><Reference><Citation>Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A. A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C. (2017) 175, 175:148&#x2013;57. doi: 10.1002/ajmg.c.31539</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31539</ArticleId><ArticleId IdType="pubmed">28145606</ArticleId></ArticleIdList></Reference><Reference><Citation>Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, et al. . The 2017 international classification of the Ehlers&#x2013;Danlos syndromes. Am J Med Genet C. (2017) 175:8&#x2013;26. doi: 10.1002/ajmg.c.31552</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31552</ArticleId><ArticleId IdType="pubmed">28306229</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagon R, Adam M, Ardinger H. Ehlers&#x2013;Danlos syndrome, hypermobility type In: GeneReviews&#xae;. Seattle, WA: University of Washington; (1993)</Citation></Reference><Reference><Citation>Kumar B, Lenert P. Joint hypermobility syndrome: recognizing a commonly overlooked cause of chronic pain. Am J Med. (2017) 130:640&#x2013;7. doi: 10.1016/j.amjmed.2017.02.013, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2017.02.013</ArticleId><ArticleId IdType="pubmed">28286166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2022) 28:611.e9. doi: 10.1016/j.cmi.2021.11.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Demmler JC, Atkinson MD, Reinhold EJ, Choy E, Lyons RA, Brophy ST. Diagnosed prevalence of Ehlers&#x2013;Danlos syndrome and hypermobility spectrum disorder in Wales, UK: a national electronic cohort study and case-control comparison. BMJ Open. (2019) 9:e031365. doi: 10.1136/bmjopen-2019-031365, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2019-031365</ArticleId><ArticleId IdType="pmc">PMC6858200</ArticleId><ArticleId IdType="pubmed">31685485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Grach SL, Ghosh AK, Bierle DM, Salonen BR, Collins NM, et al. . The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin Proc. (2022) 97:454&#x2013;64. doi: 10.1016/j.mayocp.2021.11.033, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragee B, Michos A, Drum B, Fahlgren M, Szulkin R, Bertilson BC. Signs of intracranial hypertension, hypermobility, and craniocervical obstructions in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. (2020) 11:828. doi: 10.3389/fneur.2020.00828, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00828</ArticleId><ArticleId IdType="pmc">PMC7485557</ArticleId><ArticleId IdType="pubmed">32982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Acasuso-D&#xed;az M, Collantes-Est&#xe9;vez E. Joint hypermobility in patients with fibromyalgia syndrome. Arthritis Care Res. (1998) 11:39&#x2013;42. doi: 10.1002/art.1790110107</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1790110107</ArticleId><ArticleId IdType="pubmed">9534492</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravanan V, Martin R, Kelly C. The links between fibromyalgia, hypermobility and neurodivergence. Rheumatology. (2022) 1:3. doi: 10.17925/RMD.2022.1.1.3</Citation><ArticleIdList><ArticleId IdType="doi">10.17925/RMD.2022.1.1.3</ArticleId></ArticleIdList></Reference><Reference><Citation>Eccles JA, Cadar D, Quadt L, Hakim AJ, Gall N, Bowyer V, et al. . Is joint hypermobility linked to self-reported non-recovery from COVID-19? Case-control evidence from the British COVID Symptom Study Biobank. BMJ Public Health. (2024) 2:e000478. doi: 10.1136/bmjph-2023-000478</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjph-2023-000478</ArticleId></ArticleIdList></Reference><Reference><Citation>Junkiert-Czarnecka A, Pilarska-Deltow M, Bak A, Heise M, Haus O. A novel mutation in collagen transport protein, MIA3 gene, detected in a patient with clinical symptoms of Ehlers&#x2013;Danlos hypermobile syndrome. Adv Clin Exp Med. (2023) 32:777&#x2013;81. doi: 10.17219/acem/158028, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.17219/acem/158028</ArticleId><ArticleId IdType="pubmed">36603143</ArticleId></ArticleIdList></Reference><Reference><Citation>Monjazeb R, Linjawi H, Johnson J, Laukaitis C. P254: an isolated ELN gene mutation in a patient with a complicated presentation of hypermobility. Genet Med Open. (2023) 1:100282. doi: 10.1016/j.gimo.2023.100282</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gimo.2023.100282</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wandele I, Rombaut L, De Backer T, Peersman W, Da Silva H, De Mits S, et al. . Orthostatic intolerance and fatigue in the hypermobility type of Ehlers&#x2013;Danlos syndrome. Rheumatology. (2016) 55:1412&#x2013;20. doi: 10.1093/rheumatology/kew032, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kew032</ArticleId><ArticleId IdType="pubmed">27094596</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi: 10.1038/s41579-022-00846-2, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Fiore Bavaro D, Bonica R, et al. . Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. (2023) 18:1573&#x2013;81. doi: 10.1007/s11739-022-03164-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathias CJ, Owens A, Iodice V, Hakim A. Dysautonomia in the Ehlers&#x2013;Danlos syndromes and hypermobility spectrum disorders-with a focus on the postural tachycardia syndrome. Am J Med Genet C. (2021) 187:510&#x2013;9. doi: 10.1002/ajmg.c.31951, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31951</ArticleId><ArticleId IdType="pubmed">34766441</ArticleId></ArticleIdList></Reference><Reference><Citation>Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E. Myalgic encephalomyelitis/chronic fatigue syndrome: the biology of a neglected disease. Front Immunol. (2024) 15:1386607. doi: 10.3389/fimmu.2024.1386607, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1386607</ArticleId><ArticleId IdType="pmc">PMC11180809</ArticleId><ArticleId IdType="pubmed">38887284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)&#x2014;a systemic review and comparison of clinical presentation and symptomatology. Medicina. (2021) 57:418. doi: 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Yadav S, Hurt RT, Mueller MR, Aakre CA, Gilman EA, et al. . Pro inflammatory cytokines profiles of patients with long COVID differ between variant epochs. J Prim Care Community Health. (2024) 15:21501319241254751. doi: 10.1177/21501319241254751, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501319241254751</ArticleId><ArticleId IdType="pmc">PMC11138192</ArticleId><ArticleId IdType="pubmed">38808863</ArticleId></ArticleIdList></Reference><Reference><Citation>Munipalli B, Seim L, Dawson NL, Knight D, Dabrh AMA. Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management. SN Compr Clin Med. (2022) 4:90. doi: 10.1007/s42399-022-01167-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01167-4</ArticleId><ArticleId IdType="pmc">PMC8977184</ArticleId><ArticleId IdType="pubmed">35402784</ArticleId></ArticleIdList></Reference><Reference><Citation>Arun S, Storan A, Myers B. Mast cell activation syndrome and the link with long COVID. Br J Hosp Med. (2022) 83:1&#x2013;10. doi: 10.12968/hmed.2022.0123, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/hmed.2022.0123</ArticleId><ArticleId IdType="pubmed">35938771</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavrilova N, Soprun L, Lukashenko M, Ryabkova V, Fedotkina T, Churilov L, et al. . New clinical phenotype of the post-COVID syndrome: fibromyalgia and joint hypermobility condition. Pathophysiology. (2022) 29:24&#x2013;9. doi: 10.3390/pathophysiology29010003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathophysiology29010003</ArticleId><ArticleId IdType="pmc">PMC8954589</ArticleId><ArticleId IdType="pubmed">35366287</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A, Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat Rev Cardiol. (2023) 20:281&#x2013;2. doi: 10.1038/s41569-023-00842-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller AJ, Schubart JR, Sheehan T, Bascom R, Francomano CA. Arterial elasticity in Ehlers&#x2013;Danlos syndromes. Genes. (2020) 11:55. doi: 10.3390/genes11010055</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11010055</ArticleId><ArticleId IdType="pmc">PMC7016526</ArticleId><ArticleId IdType="pubmed">31947929</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazzato D, Castori M, Lombardi R, Caravello F, Bella ED, Petrucci A, et al. . Small fiber neuropathy is a common feature of Ehlers&#x2013;Danlos syndromes. Neurology. (2016) 87:155&#x2013;9. doi: 10.1212/wnl.0000000000002847, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000002847</ArticleId><ArticleId IdType="pmc">PMC4940063</ArticleId><ArticleId IdType="pubmed">27306637</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez A, Aubry-Rozier B, Vautey M, Berna C, Suter MR. Small fiber neuropathy in hypermobile Ehlers Danlos syndrome/hypermobility spectrum disorder. J Intern Med. (2022) 292:957&#x2013;60. doi: 10.1111/joim.13539, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13539</ArticleId><ArticleId IdType="pmc">PMC9796626</ArticleId><ArticleId IdType="pubmed">35781355</ArticleId></ArticleIdList></Reference><Reference><Citation>Song L, Tian Y, Xu Z-J, Zhang C-P. Adrenaline inhibited cell proliferation and regulated expression of TGF-beta1 and bFGF in cultured human hypertrophic scar fibroblasts via alpha-receptor. EXCLI J. (2008) 7:7. doi: 10.17877/DE290R-349</Citation><ArticleIdList><ArticleId IdType="doi">10.17877/DE290R-349</ArticleId></ArticleIdList></Reference><Reference><Citation>Thong KX, Andriesei P, Luo J, Qin M, Ng J, Tagalakis AD, et al. . Adrenaline blocks key cell cycle genes and exhibits antifibrotic and vasoconstrictor effects in glaucoma surgery. Exp Eye Res. (2023) 233:109561. doi: 10.1016/j.exer.2023.109561, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exer.2023.109561</ArticleId><ArticleId IdType="pubmed">37429521</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Logarbo B, Courseault J, Wickramasuriya N, Bix G, Longo M. Long COVID and the diagnosis of underlying hypermobile Ehlers&#x2013;Danlos syndrome and hypermobility spectrum disorders (P5-4.014). Neurology. (2024) 102:17. doi: 10.1212/WNL.0000000000204558</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000204558</ArticleId><ArticleId IdType="pubmed">38116712</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakim A. Hypermobile Ehlers&#x2013;Danlos syndrome In: GeneReviews&#xae;. Seattle, WA: University of Washington; (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">20301456</ArticleId></ArticleIdList></Reference><Reference><Citation>Barron DF, Cohen BA, Geraghty MT, Violand R, Rowe PC. Joint hypermobility is more common in children with chronic fatigue syndrome than in healthy controls. J Pediatr. (2002) 141:421&#x2013;5. doi: 10.1067/mpd.2002.127496, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mpd.2002.127496</ArticleId><ArticleId IdType="pubmed">12219066</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers&#x2013;Danlos syndrome. J Pediatr. (1999) 135:494&#x2013;9. doi: 10.1016/s0022-3476(99)70173-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(99)70173-3</ArticleId><ArticleId IdType="pubmed">10518084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mudie K, Ramiller A, Whittaker S, Phillips LE. Do people with ME/CFS and joint hypermobility represent a disease subgroup? An analysis using registry data. Front Neurol. (2024) 15:1324879. doi: 10.3389/fneur.2024.1324879, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2024.1324879</ArticleId><ArticleId IdType="pmc">PMC10965591</ArticleId><ArticleId IdType="pubmed">38545281</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T, Lehoczki A, Fekete M, Varnai R, Zavori L, Erdo-Bonyar S, et al. . Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. GeroScience. (2024) 15:17. doi: 10.1007/s11357-024-01165-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-024-01165-5</ArticleId><ArticleId IdType="pmc">PMC11336094</ArticleId><ArticleId IdType="pubmed">38668888</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B, Charlton BT, Goulding RP, Kerkhoff TJ, Breedveld EA, Noort W, et al. . Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. (2024) 15:17. doi: 10.1038/s41467-023-44432-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiarelli N, Zoppi N, Ritelli M, Venturini M, Capitanio D, Gelfi C, et al. . Biological insights in the pathogenesis of hypermobile Ehlers&#x2013;Danlos syndrome from proteome profiling of patients&#x2019; dermal myofibroblasts. Biochim Biophys Acta Mol Basis Dis. (2021) 1867:166051. doi: 10.1016/j.bbadis.2020.166051, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2020.166051</ArticleId><ArticleId IdType="pubmed">33383104</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer PM, Scherer Alves L, Lvova M, Huang J, Rathi K, Janssen K, et al. . Combination of common mtDNA variants results in mitochondrial dysfunction and a connective tissue dysregulation. Proc Natl Acad Sci USA. (2022) 119:e2212417119. doi: 10.1073/pnas.2212417119, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2212417119</ArticleId><ArticleId IdType="pmc">PMC9659340</ArticleId><ArticleId IdType="pubmed">36322731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson GN, Tonk VS. Mitochondrial dysfunction contributes to Ehlers&#x2013;Danlos syndrome&#x2014;a patient presentation. J Biol Life Sci. (2020) 11:190. doi: 10.5296/jbls.v11i2.17756</Citation><ArticleIdList><ArticleId IdType="doi">10.5296/jbls.v11i2.17756</ArticleId></ArticleIdList></Reference><Reference><Citation>Courseault J, Kingry C, Morrison V, Edstrom C, Morrell K, Jaubert L, et al. . Folate-dependent hypermobility syndrome: a proposed mechanism and diagnosis. Heliyon. (2023) 9:e15387. doi: 10.1016/j.heliyon.2023.e15387, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e15387</ArticleId><ArticleId IdType="pmc">PMC10122021</ArticleId><ArticleId IdType="pubmed">37095957</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavan PG, Stecco A, Stern R, Stecco C. Painful connections: densification versus fibrosis of fascia. Curr Pain Headache Rep. (2014) 18:1&#x2013;8. doi: 10.1007/s11916-014-0441-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-014-0441-4</ArticleId><ArticleId IdType="pubmed">25063495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann A, Chery C, Coelho D, Flayac J, Gueguen N, Desquiret-Dumas V, et al. . Mutations in MTHFR and POLG impaired activity of the mitochondrial respiratory chain in 46-year-old twins with spastic paraparesis. J Hum Genet. (2020) 65:91&#x2013;8. doi: 10.1038/s10038-019-0689-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s10038-019-0689-y</ArticleId><ArticleId IdType="pubmed">31645654</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordoni L, Petracci I, Mlodzik-Czyzewska M, Malinowska AM, Szwengiel A, Sadowski M, et al. . Mitochondrial DNA and epigenetics: investigating interactions with the one-carbon metabolism in obesity. Oxidative Med Cell Longev. (2022) 2022:9171684&#x2013;12. doi: 10.1155/2022/9171684, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/9171684</ArticleId><ArticleId IdType="pmc">PMC8817841</ArticleId><ArticleId IdType="pubmed">35132354</ArticleId></ArticleIdList></Reference><Reference><Citation>Logarbo B, Yang M, Longo M, Kingry C, Courseault J. Long COVID and the diagnosis of underlying hypermobile Ehlers&#x2013;Danlos syndrome and hypermobility spectrum disorders. PM R. (2023) 16:935. doi: 10.1002/pmrj.13120</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.13120</ArticleId><ArticleId IdType="pubmed">38116712</ArticleId></ArticleIdList></Reference><Reference><Citation>Yearoo TB, Kelly C. P033&#x2014;the intriguing association between fibromyalgia, hypermobility and neurodivergence: a pilot study. Rheumatology. (2022) 61:keac133.032. doi: 10.1093/rheumatology/keac133.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keac133.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Casanova EL, Baeza-Velasco C, Buchanan CB, Casanova MF. The relationship between autism and Ehlers&#x2013;Danlos syndromes/hypermobility spectrum disorders. J Pers Med. (2020) 10:260. doi: 10.3390/jpm10040260</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10040260</ArticleId><ArticleId IdType="pmc">PMC7711487</ArticleId><ArticleId IdType="pubmed">33271870</ArticleId></ArticleIdList></Reference><Reference><Citation>Garreth Brittain M, Flanagan S, Foreman L, Teran-Wodzinski P. Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers&#x2013;Danlos syndrome: a scoping review. Disabil Rehabil. (2024) 46:1936&#x2013;53. doi: 10.1080/09638288.2023.2216028, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2023.2216028</ArticleId><ArticleId IdType="pubmed">37231592</ArticleId></ArticleIdList></Reference><Reference><Citation>Reychler G, De Backer MM, Piraux E, Poncin W, Caty G. Physical therapy treatment of hypermobile Ehlers&#x2013;Danlos syndrome: a systematic review. Am J Med Genet A. (2021) 185:2986&#x2013;94. doi: 10.1002/ajmg.a.62393, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.a.62393</ArticleId><ArticleId IdType="pubmed">34145717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Fischer PR, Brands CK, Fisher JL, Porter CBJ, Driscoll SW, et al. . Do people with benign joint hypermobility syndrome (BJHS) have reduced joint proprioception? A systematic review and meta-analysis. Rheumatol Int. (2013) 33:2709&#x2013;16. doi: 10.1007/s00296-013-2790-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-013-2790-4</ArticleId><ArticleId IdType="pubmed">23728275</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins SM, Cossette-Levasseur M, Kikuchi K, Sarjeant J, Shiu YG, Azar C, et al. . Neuromuscular activation differences during gait in patients with Ehlers&#x2013;Danlos syndrome and healthy adults. Arthritis Care Res. (2020) 72:1653&#x2013;62. doi: 10.1002/acr.24067, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.24067</ArticleId><ArticleId IdType="pubmed">31498548</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmonds JV, Keer RJ. Hypermobility and the hypermobility syndrome. Man Ther. (2007) 12:298&#x2013;309. doi: 10.1016/j.math.2007.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.math.2007.05.001</ArticleId><ArticleId IdType="pubmed">17643337</ArticleId></ArticleIdList></Reference><Reference><Citation>Grach SL, Seltzer J, Chon TY, Ganesh R. Diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome. Mayo Clin Proc. (2023) 98:1544&#x2013;51. doi: 10.1016/j.mayocp.2023.07.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2023.07.032</ArticleId><ArticleId IdType="pubmed">37793728</ArticleId></ArticleIdList></Reference><Reference><Citation>Contreras AM, Newman DB, Cappelloni L, Niven AS, Mueller MR, Ganesh R, et al. . Cardiopulmonary testing in long COVID-19 versus non-COVID-19 patients with undifferentiated dyspnea on exertion. Prog Cardiovasc Dis. (2024) 83:71&#x2013;6. doi: 10.1016/j.pcad.2023.05.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pcad.2023.05.005</ArticleId><ArticleId IdType="pmc">PMC10198738</ArticleId><ArticleId IdType="pubmed">37211198</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedry SE, Langley BO, Schaefer K, Hanes DA. Patient experience of chronic illness care and complementary integrative health use: a cross-sectional study of patients with hypermobility spectrum disorders (HSD) and Ehlers&#x2013;Danlos syndromes (EDS). Disabil Rehabil. (2023) 45:3549&#x2013;59. doi: 10.1080/09638288.2022.2131003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2022.2131003</ArticleId><ArticleId IdType="pubmed">36222285</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwell K, Michael W, Dubey J, James S, Martonffy A, Anderson S, et al. . Diagnosis and management of hypermobility spectrum disorders in primary care. J Am Board Fam Med. (2021) 34:838&#x2013;48. doi: 10.3122/jabfm.2021.04.200374, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3122/jabfm.2021.04.200374</ArticleId><ArticleId IdType="pubmed">34312277</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra P, Tinkle B, Hamonet C, Brock I, Gompel A, Bulbena A, et al. . Pain management in the Ehlers&#x2013;Danlos syndromes. Am J Med Genet C. (2017) 175:212&#x2013;9. doi: 10.1002/ajmg.c.31554</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.c.31554</ArticleId><ArticleId IdType="pubmed">28186390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross AJ, Ocon AJ, Medow MS, Stewart JM. A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome. Clin Sci. (2014) 126:289&#x2013;96. doi: 10.1042/cs20130222, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/cs20130222</ArticleId><ArticleId IdType="pmc">PMC3896075</ArticleId><ArticleId IdType="pubmed">23978222</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai CC, Fischer PR, Brands CK, Fisher JL, Porter CBJ, Driscoll SW, et al. . Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers. Pacing Clin Electrophysiol. (2009) 32:234&#x2013;8. doi: 10.1111/j.1540-8159.2008.02207.x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.2008.02207.x</ArticleId><ArticleId IdType="pubmed">19170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas J, Santos R, Azevedo E, Costa O, Carvalho M, de Freitas AF. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Clin Auton Res. (2000) 10:293&#x2013;9. doi: 10.1007/bf02281112, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf02281112</ArticleId><ArticleId IdType="pubmed">11198485</ArticleId></ArticleIdList></Reference><Reference><Citation>Younger J, Noor N, McCue R, Mackey S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. (2013) 65:529&#x2013;38. doi: 10.1002/art.37734, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37734</ArticleId><ArticleId IdType="pubmed">23359310</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabanas H, Muraki K, Staines D, Marshall-Gradisnik S. Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients. Front Immunol. (2019) 10:2545. doi: 10.3389/fimmu.2019.02545, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02545</ArticleId><ArticleId IdType="pmc">PMC6834647</ArticleId><ArticleId IdType="pubmed">31736966</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>